Boothbay Fund Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,968
| Closed | -$8.36K | – | 2286 |
|
|
2023
Q1 | $8.36K | Hold |
11,968
| – | – | ﹤0.01% | 1826 |
|
|
2022
Q4 | $10.8K | Hold |
11,968
| – | – | ﹤0.01% | 1690 |
|
|
2022
Q3 | $72K | Sell |
11,968
-52,872
| -82% | -$318K | ﹤0.01% | 1799 |
|
|
2022
Q2 | $268K | Hold |
64,840
| – | – | 0.01% | 1326 |
|
|
2022
Q1 | $246K | Hold |
64,840
| – | – | 0.01% | 1381 |
|
|
2021
Q4 | $292K | Hold |
64,840
| – | – | 0.01% | 1122 |
|
|
2021
Q3 | $302K | Sell |
64,840
-20,073
| -24% | -$93.5K | 0.01% | 1106 |
|
|
2021
Q2 | $599K | Buy |
84,913
+1,421
| +2% | +$10K | 0.02% | 801 |
|
|
2021
Q1 | $493K | Buy |
+83,492
| New | +$493K | 0.02% | 775 |
|
|
2020
Q3 | – | Sell |
-28,350
| Closed | -$815K | – | 1189 |
|
|
2020
Q2 | $815K | Buy |
+28,350
| New | +$815K | 0.06% | 371 |
|